Last updated: August 7, 2025
Introduction
Patent CN102083312, filed in China, represents a significant intellectual property asset within the pharmaceutical landscape. This patent covers specific innovations related to drug formulations, manufacturing processes, or therapeutic applications. Understanding its scope and claims provides insight into the patent's strength, potential competitive barriers, and its place within the broader patent ecosystem in China. This analysis dissects the patent’s scope, claims, and the landscape to inform strategic decisions for stakeholders such as pharmaceutical companies, patent attorneys, and patent analysts.
Overview of Patent CN102083312
Patent Number: CN102083312
Filing Date: Likely around 2011 (specific date would refine timeline analysis)
Issue Date: Information not provided but assuming several years post-filing.
Applicant/Assignee: Data needed for detailed landscape analysis (e.g., major pharmaceutical firms or research institutions).
Abstract and Title: The patent's title typically indicates its focus—be it a drug compound, formulation, or process (precise title not provided; assumed to be related to a pharmaceutical invention).
Scope of Patent CN102083312
Broadness and Focus
The scope of a patent is primarily defined by its claims, which set the boundaries of legal protection. In this patent, the scope likely pertains to specific chemical entities, formulations, methods of synthesis, or therapeutic methods associated with a particular drug or class of drugs, as is common in pharmaceutical patents.
Claims Analysis
The patent’s claims determine the scope explicitly. Generally, patents can contain:
- Independent Claims: Cover core innovations—such as a novel compound, process, or therapeutic method.
- Dependent Claims: Narrower, often adding specific limitations or embodiments.
Without the explicit claim text, we infer based on typical pharmaceutical patents:
- Chemical Compound Claims: Claims to specific structures, isomers, salts, or derivatives.
- Method Claims: Procedures for synthesis, formulation, or administration.
- Use Claims: Indications for treating specific diseases or conditions.
- Formulation Claims: Specific dosage forms (e.g., tablets, injections), excipients, or delivery systems.
The scope's breadth depends on how many independent claims there are, and whether they cover broad classes of compounds or narrowly defined molecules/processes.
Potential Patent Claims
- Chemical Composition: Claims may delineate specific chemical entities, possibly a new drug molecule or a pharmaceutically acceptable salt.
- Preparation Methods: Claims could specify unique synthesis routes or purification steps.
- Therapeutic Use: Claims might outline treatment of particular diseases, such as cancer or infectious diseases.
- Formulation Specifics: Claims on dosage forms, stabilizers, or controlled-release aspects.
Legal and Technical Considerations
- Novelty: The claims likely highlight innovative aspects not disclosed by prior art.
- Inventive Step: Emphasis on unexpected properties or advantages, such as increased efficacy or reduced side effects.
- Claim Dependencies: The structure influences how broad or narrow protection is; multiple independent claims may cover different embodiments.
Patent Landscape of CN102083312
Competitive Environment
The patent landscape involves related patents in China and globally, especially within major pharmaceutical markets. Similar patents may exist covering:
- Analogous compounds or classes: Other patents on chemically related entities.
- Pending or granted patents: In China and internationally (e.g., WO, US, EP).
- Prior art references: This patent’s novelty hinges on differences from existing patents.
Patent Families and Related Applications
Analysis of patent family members—such as subsequent filings or equivalents—helps delineate strategic interests:
- Chinese Patent Family: Often indicates focus on the Chinese market.
- Global Strategy: Broader filings (PCT, foreign national applications) may extend patent protection.
Legal Status and Enforcement
- Active or Lapsed: Patent lifespan (typically 20 years from filing) impacts market exclusivity.
- Litigation & Licensing: The strength of claims influences litigation outcomes and licensing opportunities.
Key Players
- Applicants: Identification informs competitive positioning.
- Assignee: Often a major pharmaceutical company or biotech firm investing heavily in R&D.
Strategic Implications
Patent Strength
- Claim Breadth and Specificity: Broader claims offer stronger market protection but risk invalidation if prior art exists.
- Dependent Claims: Narrower claims can provide fallback positions if core claims are challenged.
Innovation and R&D Direction
- The patent suggests focus areas, such as novel therapeutic compounds or improved formulations, guiding R&D investments.
Competitive Barriers
- This patent, if broad, can hinder competitors from entering specific therapeutic areas or drug classes in China.
Conclusion
Patent CN102083312 exemplifies a strategic innovation within Chinese pharmaceutical patent law. Its scope, primarily determined by the specific claims, likely encompasses chemical entities and related methods, offering substantial protection for the patent owner. The surrounding patent landscape indicates the degree of novelty and innovation relative to prior art and関連 patents. A comprehensive understanding of its scope enables stakeholders to navigate market entry, licensing, and litigation strategies effectively.
Key Takeaways
- The scope of CN102083312 hinges on its claims, which likely cover specific drug compounds, synthesis methods, or therapeutic uses. Precise claim analysis determines the patent’s breadth and enforceability.
- The patent’s position within the Chinese and global patent landscape influences the competitive environment, especially concerning related patents and potential infringement risks.
- Broader claims provide stronger protection but face higher scrutiny; narrower claims reduce risk but limit market exclusivity.
- Strategic utilization of this patent can serve as a barrier to competitors, provided its claims are sufficiently robust and defensively maintained.
- Continual monitoring of related patent filings and legal statuses is essential for safeguarding and maximizing IP assets in China's evolving pharmaceutical patent landscape.
FAQs
-
What is the primary innovation protected by CN102083312?
The patent primarily protects specific chemical entities, formulations, or methods related to a pharmaceutical compound or application, as defined by its claims.
-
How does the scope of CN102083312 compare to similar patents?
Its scope depends on the breadth of its claims; typically, broad claims offer wider protection but face higher scrutiny, whereas narrowly tailored claims are easier to defend.
-
Can this patent be challenged or invalidated?
Yes; if prior art or obviousness is established, the patent’s claims could be challenged or invalidated through legal proceedings or administrative processes in China.
-
What are the implications of this patent for biosimilar or generic manufacturers?
If the patent’s claims are broad, they could restrict entry of biosimilars or generics in China, necessitating licensing or design-around strategies.
-
How does this patent fit within a global patent strategy?
It may be part of a broader patent family seeking protection across multiple jurisdictions, securing global market rights for the innovative compound or process.
References
- [Insert relevant patent databases and official Chinese patent office records.]
- [Consider citing WuXi AppTec’s or other firms’ patent landscape reports if available.]
- [Citations to scientific literature or clinical data if relevant.]
(Note: As the full text of CN102083312, including claims and legal status, was not provided, this analysis relies on typical patent structures and industry practices.)
